Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Dolutegravir Expanded Access Study (DEAP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01536873
Recruitment Status : Completed
First Posted : February 22, 2012
Last Update Posted : September 30, 2020
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by (Responsible Party):
ViiV Healthcare

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : September 23, 2016
Actual Study Completion Date : September 23, 2016